relationships relevant to the contents of this paper to disclose. Collecting the available data from the present study and other many papers on different imaging techniques in CA ( 
Troponin (14) Amyloidotic burden þ þ þ þ À
Response to therapy þ þ þ ? ? þþ? 6MWT ?
*Late gadolinium enhancement extracellular volume and native T1 mapping.
þþþ ¼ very useful, recommended; þþ and þAE ¼ useful, to be considered; þ ¼ possibly useful; þ/À ¼ role uncertain; À ¼ not useful; 6MWT ¼ 6-min walk test; ATTR ¼ transthyretin-related amyloidosis; CA ¼ cardiac amyloidosis; CMR ¼ cardiac magnetic resonance; Echo ¼ echocardiography; MIBG ¼ meta iodine-131-metaiodobenzylguanidine; NT-proBNP ¼ N-terminal pro-B-type natriuretic protein.
